Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2107507118Source: DataRank Database

Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 91 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access91 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.02)OA: greenTopics (37)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Sandra Toregrosa-Allen,Bennett D. Elzey ORCID,Sagar M. Utturkar ORCID,Nadia A. Lanman ORCID,Victor Bernal-Crespo ORCID

Live enrichment

PubMed:34740973 PMC:PMC8609337 OpenAlex:https://openalex.org/W3209790238

V Foundation for Cancer Research

Grant: D2019-039

Walther Cancer Foundation

Grant: 0186.01

National Institutes of Health

Grant: P30 CA023168

National Institutes of Health

Grant: P30 CA082709

FWCI

5.02

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://www.pnas.org/site/aboutpnas/licenses.xhtml

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8609337

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609337

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8609337

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2107507118

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2107507118

Fields of Study

CAR-T cell therapy researchImmune Cell Function and InteractionGlioma Diagnosis and TreatmentMedicineEngineeringAnimalsAutophagyGenetic EngineeringGlioblastomaHumansImmunotherapy, AdoptiveKiller Cells, NaturalMiceTumor MicroenvironmentXenograft Model Antitumor Assays

MeSH Terms

AnimalsAutophagyGenetic EngineeringGlioblastomaHumansKiller Cells, NaturalImmunotherapy, AdoptiveXenograft Model Antitumor AssaysMiceTumor Microenvironment

Keywords

GlioblastomaTumor microenvironmentCancer researchGenetically engineeredTumor cellsBiologyGeneGeneticsImmunotherapyNatural killer cellsAutophagyCd73

Additional file 1 of Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion

10.6084/m9.figshare.25107797.v1figshare

Additional file 2 of Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion

10.6084/m9.figshare.25107910.v1figshare

Additional file 1 of Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion

10.6084/m9.figshare.25107797figshare

Additional file 2 of Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion

10.6084/m9.figshare.25107910figshare